Synthesis and utilization of β-cyclodextrin modified chitosan for the adsorption of aspirin /

Synthesis and utilization of β-cyclodextrin modified chitosan for the adsorption of aspirin /

Show other versions (1)

Bibliographic Details
Main Author:	Muhammad Asyiq Azman, 1994-, author 625446
Format:	text
Language:	eng
Published:	Johor Bahru, Johor : Universiti Teknologi Malaysia, 2019
Subjects:	Aspirin Chitosan

Similar Items

Synthesis and utilization of β-cyclodextrin modified chitosan for the adsorption of aspirin /
by: Muhammad Asyiq Azman, 1994-, author 625446, et al.
Published: (2019)

Polyethyleneimine modified acid treated spent tea as adsorbent for aspirin removal /
by: Norfiona Rosli, 1993-, author 631596
Published: (2020)

Aspirin : the miracle drug /
by: 296334 Metcalf, Eric
Published: (2005)

Polyethyleneimine modified acid treated spent tea as adsorbent for aspirin removal /
by: Norfiona Rosli, 1993-, author 631596, et al.
Published: (2020)

Aspirin tablets
by: 982 SIRIM

Aspirin/amoxicillin loaded chitosan microparticles and polydopamine modified titanium implants to combat infections and promote osteogenesis
by: Yun Shi, et al.
Published: (2024-04-01)

Facile fabrication of a biocompatible composite gel with sustained release of aspirin for bone regeneration
by: Yunfan Zhang, et al.
Published: (2022-05-01)

Modification of carbon black using polyethylenimine (PEI) for aspirin removal /
by: Dyg Khairunnisa Awg Zaini, 1994-, author 625462
Published: (2019)

Artificial intelligence, platelets and aspirin
by: Giovanni de Gaetano
Published: (2024-03-01)

Curing of Escherichia coli Antibiotic Resistance Plasmids by Aspirin
by: Ibtesam H. Al Musawi, et al.
Published: (2014-01-01)

Blood platelets, prostaglandins and aspirin: a historical and personal rereading
by: Giovanni de Gaetano, et al.
Published: (2024-03-01)

Removal of aspirin in aqueous using activated carbon derived from spent tea leaves /
by: Lee, Nicholas Yow Jeng, 1991-, author 641832
Published: (2016)

Modification of carbon black using polyethylenimine (PEI) for aspirin removal /
by: Dyg Khairunnisa Awg Zaini, 1994-, author 625462, et al.
Published: (2019)

Pharmacodynamic Comparison of Two Aspirin Formulations in the Caribbean: The ARC Study
by: Naveen Seecheran, et al.
Published: (2024-07-01)

US population qualifying for aspirin use for primary prevention of cardiovascular disease
by: Athena L. Huang, et al.
Published: (2024-06-01)

Removal of aspirin in aqueous using activated carbon derived from spent tea leaves /
by: Lee, Nicholas Yow Jeng, 1991-, author 641832, et al.
Published: (2016)

TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN
by: A. I. Martynov, et al.
Published: (2015-09-01)

Comparative study on adsorption of copper ions using chitosan beads and chitosan flakes /
by: Nur Hidayah Mohd. Ran, 1987-, et al.
Published: (2009)

The effects of aspirin and fenugreek seed on the testes of white mice
by: Amal K. Chaloob, et al.
Published: (2010-10-01)

ASPIRIN RESISTANCE CANDIDATE GENES AND THEIR ASSOCIATION WITH THE RISK OF CARDIOVASCULAR EVENTS
by: Yu. I. Grinshtein, et al.
Published: (2013-02-01)

Synthesis and physicochemical characterization of chitosan-modified membranes as potential wound dressing /
by: 626143 Thiviya Selvaras, 1996- author
Published: (2019)

Analisa kuantitatif aspirin didalam beberapa jenama tablet analgesik dengan kaedah ultra-lembayong/
by: 237263 Zainon Mustaffa

Synthesis and characterization of chitosan ethers: Hydroxypropyl chitosan and Hydroxyethyl chitosan
by: Mehmet Tumer, et al.
Published: (2024-06-01)

Aspirin for preeclampsia prevention in low- and middle-income countries: mind the gaps
by: Ellen Kupka, MD, et al.
Published: (2024-05-01)

APC tablets (containing aspirin, phenacetin and caffeine)
by: 982 SIRIM

Synthesis and physicochemical characterization of chitosan-modified membranes as potential wound dressing /
by: 626143 Thiviya Selvaras, 1996- author, et al.
Published: (2019)

The Incidence and Methods for Detecting Aspirin Resistance in Pediatric Patients
by: Poparn H, et al.
Published: (2024-11-01)

PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN DIABETES MELLITUS: THE ROLE OF ASPIRIN
by: L. A. Strizhakov
Published: (2012-04-01)

Daily low‐dose aspirin and blood pressure in community‐dwelling older adults
by: Michael E. Ernst, et al.
Published: (2024-10-01)

Association between discontinuation of aspirin and perioperative bleeding or ischemic events before neurosurgery
by: WANG Xin-yan, WANG Xin-xin, YU Yun, HAN Ru-quan
Published: (2022-02-01)

IJCM_19A: Aspirin delays the onset of hypertensive disorders of pregnancy among nulliparous pregnant women: a secondary analysis of the ASPIRIN Trial
by: Kavi Avinash, et al.
Published: (2024-04-01)

Effect of Aspirin on Sperm Specification and Some Hematological Parameters in Male Albino White Rat
by: Bilal S. D. Al-Taei
Published: (2014-12-01)

Evaluation of extraction of teeth without alteration in aspirin therapy: A cross sectional study
by: Ahmed Ali Almuntashri, et al.
Published: (2024-01-01)

Microneedle-Assisted Transfersomes as a Transdermal Delivery System for Aspirin
by: Raha Rahbari, et al.
Published: (2023-12-01)

Role of aspirin in cancer prevention
by: Meng Sun, et al.
Published: (2024-01-01)

Comparison of the efficacy of 75 mg aspirin versus 150 mg aspirin for prevention of preeclampsia in patients at high risk for preeclampsia
by: Dr. Natasha Bushra, et al.
Published: (2024-03-01)

Aspirin-exacerbated respiratory disease is associated with variants in filaggrin, epithelial integrity, and cellular interactions
by: Elina Jerschow, MD, MSc, et al.
Published: (2024-05-01)

ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE
by: M. G. Bubnova
Published: (2010-08-01)

Pervaporation performance of modified chitosan membranes for separation of ethanol-water mixtures /
by: Kumaran Rasentheran, 1990-, author, et al.
Published: (2013)

Pervaporation performance of modified chitosan membranes for separation of ethanol-water mixtures /
by: Kumaran Rasentheran, 1990-, author, et al.
Published: (2013)